|
|
Volumn 73, Issue 4, 2013, Pages
|
|
What's next for Alzheimer treatment?: While Aβ Isn't out of the Picture Yet, Several Other Therapeutic Routes Are Being Explored
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID BETA PROTEIN;
AMYLOID BETA PROTEIN ANTIBODY;
APOLIPOPROTEIN E4;
BAPINEUZUMAB;
BETA SECRETASE INHIBITOR;
SOLANEZUMAB;
TAU PROTEIN;
ALZHEIMER DISEASE;
ARTICLE;
BLOOD BRAIN BARRIER;
COST OF ILLNESS;
DRUG EFFICACY;
GENE MUTATION;
HUMAN;
PRIORITY JOURNAL;
UNSPECIFIED SIDE EFFECT;
ALZHEIMER DISEASE;
AMYLOID BETA-PEPTIDES;
APOLIPOPROTEIN E4;
HUMANS;
TAU PROTEINS;
|
|
EID: 84878414271
PISSN: 03645134
EISSN: 15318249
Source Type: Journal
DOI: 10.1002/ana.23900 Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
